Llwytho...
Evaluating the Long-Term Efficacy of COVID-19 Vaccines
Large-scale deployment of safe and durably effective vaccines can curtail the COVID-19 pandemic. (1−3) However, the high vaccine efficacy (VE) reported by ongoing phase 3 placebo-controlled clinical trials is based on a median follow-up time of only about two months (4−5) and thus does not pertain t...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | medRxiv |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cold Spring Harbor Laboratory
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836139/ https://ncbi.nlm.nih.gov/pubmed/33501467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.01.13.21249779 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|